Molecules + medicines
Research in this area will advance the diagnosis, treatment and prevention of human disease through understanding of disease mechanisms at the cellular and molecular level; sophisticated, personalized diagnostic tests to determine causes and therapy; and new medical interventions and preventative measures using drugs, biologics and devices.
Select KU research in this area
KU lab leads research on little-studied coronavirus structure, developing treatment
University of Kansas virologist Anthony Fehr and his lab is researching the coronavirus macrodomain — an enzyme essential in causing disease — and creating an antiviral treatment targeting the enzyme.
Biotech company with KU roots wins national competition, secures funding
Clara Biotech refined a novel technology to isolate and purify exosomes, which can be used for early disease diagnosis, targeted drug delivery, cancer immunotherapy and more.
KU researcher part of teams developing treatments for COVID-19, other infectious diseases
Scott Lovell, director of KU’s Protein Structure & X-Ray Crystallography Lab, and three collaborators received a $3.7 million grant to develop an antiviral therapeutic treatment that could help people who have contracted SARS-CoV-2.
At home COVID-19 test developed at KU moves toward production
University of Kansas researchers, led by Steven Soper, have created an at-home rapid COVID-19 test using "lab on a chip" technology. They aim to launch the product in early 2022.
KU's strengths in this area
- Alzheimer's Disease Research Center
- Center for Chemical Biology of Infectious Diseases
- Center for Genomics
- Center for Molecular Analysis of Disease Pathways
- Department of Chemistry
- Higuchi Biosciences Center
- Institute for Information Sciences
- Institute for Bioengineering Research
- KU Cancer Center
- Molecular Biosciences
- School of Pharmacy
- Vaccine Analytics Formulation Center